N	Concordance
1	t.[10]    The relatively rare malignant carcinoid syndrome (flush, diarrhea,  br
2	l therapies. Development of a malignant carcinoid syndrome indicates the presenc
3	 multiple liver metastases, presence of carcinoid syndrome and high levels of th
4	reports of successful palliation of the carcinoid syndrome by selective hepatic 
5	  The median survival for patients with carcinoid syndrome is 38 months. Long-te
6	esulting from duodenal gastrinomas, and carcinoid syndrome, caused by malignant 
7	e serotonin and cause symptoms known as carcinoid syndrome. It may also cause lo
8	carcinoid tumor are responsible for the carcinoid syndrome. We present a case of
9	tion to facilitate the treatment of the carcinoid syndrome. When midgut carcinoi
10	iorate the symptoms associated with the carcinoid syndrome.[58] Octreotide has b